Showing results (91-100 of 106) with videos related to

Sort By:
Pageof 11
Leukemia & Lymphoma|August 2, 2021
A phase I/II trial of brentuximab vedotin plus rituximab as frontline therapy for patients with immunosuppression-associated CD30+ and/or EBV + lymphomasWilliam B Pearse, Adam M Petrich, Leo I Gordon, et al.
Blood Advances|January 18, 2024
A phase 1-2 trial of DA-EPOCH-R plus ixazomib for MYC-aberrant lymphoid malignancies: the DACIPHOR regimenReem Karmali, Carlos Galvez, Mehdi Hamadani, et al.
Plos One|April 18, 2012
Candidate gene sequencing of SLC11A2 and TMPRSS6 in a family with severe anaemia: common SNPs, rare haplotypes, no causative mutationAnita Kloss-Brandstätter, Gertraud Erhart, Claudia Lamina, et al.
Journal of Medicinal Chemistry|February 5, 2026
Multiparameter Optimization of Pseudomonas aeruginosa Elastase Inhibitors for Systemic AdministrationAhmed S Abdelsamie, Jelena Konstantinović, Andreas M Kany, et al.
Blood Advances|December 31, 2021
Pembrolizumab plus dinaciclib in patients with hematologic malignancies: the phase 1b KEYNOTE-155 studyGareth P Gregory, Shaji Kumar, Ding Wang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 1, 2016
Success of an International Learning Health Care System in Hematopoietic Cell Transplantation: The American Society of Blood and Marrow Transplantation Clinical Case ForumPere Barba, Linda J Burns, Mark R Litzow, et al.
Leukemia & Lymphoma|April 8, 2025
Hematology-oncology provider perspectives regarding lymphoma treatment and cardioprotective strategies in patients with lymphoma at high risk for heart failureEmily Anderson, Yun Choi, Rachel J Buchsbaum, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 20, 2025
Dipeptidic Phosphonates: Potent Inhibitors of Pseudomonas aeruginosa Elastase B Showing Efficacy in a Murine Keratitis ModelAlexander F Kiefer, Christian Schütz, Colya N Englisch, et al.
The New England Journal of Medicine|May 10, 2002
Germ-line mutations in nonsyndromic pheochromocytomaHartmut P H Neumann, Birke Bausch, Sarah R McWhinney, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 9, 2015
Reduced-Intensity Allografting as First Transplantation Approach in Relapsed/Refractory Grades One and Two Follicular Lymphoma Provides Improved Outcomes in Long-Term SurvivorsEvgeny Klyuchnikov, Ulrike Bacher, Nicolaus M Kröger, et al.
Pageof 11